Overview Fundamentals API Earnings EOD API Sample Code Pricing

Verici Dx plc (VRCDF PINK) stock market data APIs

$0.09 0(0%) as of September 9, 2024
Price chart is built with Anychart

Verici Dx plc develops prognostic and diagnostic tests for kidney transplant patients. Its lead products are Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company is also developing Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Cardiff, the United Kingdom.

Verici Dx plc Financial Data Overview

0.09
0.09
-
0.09
0.09
0.085-0.2
21 829 K
243 M
4 333 K
1.591
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'VRCDF',
Type: 'Common Stock',
Name: 'Verici Dx plc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG013FDBYW5',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: NULL,
IsDelisted: false,
}

Verici Dx plc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 333 K
  • EBITDA -3 742 000
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Verici Dx plc Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Verici Dx plc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com